ATP6AP1 and breast carcinoma: To further explore the impact of ATP6AP1 on TAM resistance, we verified the effect of CQ (an autophagy inhibitor) or Bafilomycin-A1 (BafA1, a V-ATPase inhibitor) on TAM resistance in luminal breast cancer cells.